The efficacy and safety of currently approved and pipeline medications for moderate-to-severe hidradenitis suppurativa (HS) are compared in a systematic literature review and network meta-analysis published online July 2 in JAMA Dermatology.
from Medical Xpress - latest medical and health news stories https://ift.tt/xU2yEul
